Decision This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) ● – Topical Agents for Psoriasis Discussion Mr. Calloway reviewed the criteria document, reviewing preferred and non-preferred – agents. Decision This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) ● – Topical Androgenic Agents Discussion Mr. Calloway reviewed the criteria document, reviewing preferred and non-preferred – agents. Decision This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) ● – Topical Antifungals Discussion Mr. Calloway reviewed the criteria document, reviewing preferred and non-preferred – agents. Decision This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) ● – Topical Antiparasitics Discussion Mr. Calloway stated are no changes recommended for this class. – Decision This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) ● – Topical Antivirals Discussion Mr. Calloway stated there are no changes recommended for this class. – Decision This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) ● – Mr. Calloway reviewed the criteria document, reviewing preferred and non-preferred Topical Immunomodulators Discussion – agents. Decision This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) ● – Topical Retinoids Discussion Mr. Calloway reviewed the criteria document, reviewing preferred and non-preferred – agents. Decision This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) ● – Topical Steroids Discussion Mr. Calloway reviewed the criteria document, reviewing preferred and non-preferred – agents. This PDL recommendation was accepted and added to the block vote. Decision (See Roll Call Votes) ● – Ulcerative Colitis Agents Discussion Mr. Calloway reviewed the criteria document, reviewing preferred and non-preferred – – Oral agents. Decision This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) ● – Ulcerative Colitis Agents Discussion Mr. Calloway stated there are no changes recommended for this class. – This PDL recommendation was accepted and added to the block vote. Rectal Decision (See Roll Call Votes) ● –
● Decision – This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) Topical Agents for Psoriasis Discussion – Mr. Calloway reviewed the criteria document, reviewing preferred and non-preferred agents. ● Decision – This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) Topical Androgenic Agents Discussion – Mr. Calloway reviewed the criteria document, reviewing preferred and non-preferred agents. ● Decision – This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) Topical Antifungals Discussion – Mr. Calloway reviewed the criteria document, reviewing preferred and non-preferred agents. ● Decision – This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) Topical Antiparasitics Discussion – Mr. Calloway stated are no changes recommended for this class. ● Decision – This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) Topical Antivirals Discussion – Mr. Calloway stated there are no changes recommended for this class. ● Decision – This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) Topical Immunomodulators Discussion – Mr. Calloway reviewed the criteria document, reviewing preferred and non-preferred agents. ● Decision – This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) Topical Retinoids Discussion – Mr. Calloway reviewed the criteria document, reviewing preferred and non-preferred agents. ● Decision – This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) Topical Steroids Discussion – Mr. Calloway reviewed the criteria document, reviewing preferred and non-preferred agents. ● Decision – This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) Ulcerative Colitis Agents – Oral Discussion – Mr. Calloway reviewed the criteria document, reviewing preferred and non-preferred agents. ● Decision – This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes) Ulcerative Colitis Agents Rectal Discussion – Mr. Calloway stated there are no changes recommended for this class. ● Decision – This PDL recommendation was accepted and added to the block vote. (See Roll Call Votes)
160416-minutes-drug-utilization-review.docx